AAAAAA

   
Results: 1-3 |
Results: 3
EXPRESSION OF THE KIDNEY-ASSOCIATED DIFFERENTIATION GLYCOPROTEIN GP160 AND RESISTANCE TO THE ANTITUMOR EFFECTS OF INTERFERON A IN RENAL-CELL CARCINOMAS
Authors: GENG YP BIFFI A ENGELSTEIN D RONCH E FAUSTINI M LAI HK ALBINO AP DIFRONZO G NANUS DM
Citation: Yp. Geng et al., EXPRESSION OF THE KIDNEY-ASSOCIATED DIFFERENTIATION GLYCOPROTEIN GP160 AND RESISTANCE TO THE ANTITUMOR EFFECTS OF INTERFERON A IN RENAL-CELL CARCINOMAS, Anticancer research, 18(1A), 1998, pp. 1-7
DEXAMETHASONE PLUS ONDANSETRON VERSUS DEXAMETHASONE PLUS ALIZAPRIDE IN THE PREVENTION OF EMESIS INDUCED BY CISPLATIN-CONTAINING CHEMOTHERAPIES FOR UROLOGICAL CANCERS
Authors: NICOLAI N MANGIAROTTI B SALVIONI R PIVA L FAUSTINI M PIZZOCARO G
Citation: N. Nicolai et al., DEXAMETHASONE PLUS ONDANSETRON VERSUS DEXAMETHASONE PLUS ALIZAPRIDE IN THE PREVENTION OF EMESIS INDUCED BY CISPLATIN-CONTAINING CHEMOTHERAPIES FOR UROLOGICAL CANCERS, European urology, 23(4), 1993, pp. 450-456
MODIFIED CISPLATIN, ETOPOSIDE (OR VINBLASTINE) AND IFOSFAMIDE SALVAGETHERAPY FOR MALE GERM-CELL TUMORS - LONG-TERM RESULTS
Authors: PIZZOCARO G SALVIONI R PIVA L FAUSTINI M NICOLAI N GIANNI L
Citation: G. Pizzocaro et al., MODIFIED CISPLATIN, ETOPOSIDE (OR VINBLASTINE) AND IFOSFAMIDE SALVAGETHERAPY FOR MALE GERM-CELL TUMORS - LONG-TERM RESULTS, Annals of oncology, 3(3), 1992, pp. 211-216
Risultati: 1-3 |